Company / Operating Cash Flow per Share
Catalyst Pharmaceuticals Partners, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$1.70
FY2025
5-year range
$0.59 / $1.98
FY2021-FY2025
Trend
-14.1%
vs FY2024
Sector context
#44 of 212
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s operating cash flow per share of $1.70 is higher than 79% of companies in the Health Care sector (FY2025). Improved from $1.34 to $1.70 over the past 2 years.
Based on SEC 10-K filings.
1.70 in FY2025 with a 5-year CAGR of +31.4%. Top quartile in the Health Care sector.
Improved from $1.34 to $1.70 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +15.6%
- 5-Year CAGR
- +31.4%
- 10-Year CAGR
- -
Sector benchmark
+111.6% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 14.1% year-over-year.
- Ranks #44 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.70 | -14.1% |
| FY2024 | $1.98 | +48.0% |
| FY2023 | $1.34 | +21.6% |
| FY2022 | $1.10 | +88.1% |
| FY2021 | $0.59 | +34.6% |
| FY2020 | $0.44 | +29.3% |
| FY2019 | $0.34 | +232.1% |
| FY2018 | -$0.25 | -17.4% |
| FY2017 | -$0.22 | -0.3% |
| FY2016 | -$0.22 | +0.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026